We want to develop neoantigen mRNA vaccines for pediatric brain tumors and translate this new immunotherapy into clinical trials to help these devastating tumors. CBTN specimens will help us identify the effective neoantigen targets for mRNA vaccine development and manufacturing.
Get the Latest
news, articles, and resources sent to your inbox.
